Researchers have developed smart wound dressings using magnesium hydroxide nano sheets that will alert patients when a wound is not properly healing.
Researchers discover process behind molecule that improves appearance of surgical scars
Researchers at Virginia Tech (VTC) have uncovered how the alphaCT1 molecule influences the behavior of collagen-producing fibroblasts. Prior research had shown that treating scars with the molecule produced long-term improvement, but the mechanism of action was unclear.
Handwashing and domestic hygiene practices should not impair childhood immunity, new study suggests
According to a new study, increased hand washing and domestic hygiene practices need not conflict with the ‘hygiene hypothesis’, which states that early exposure to microorganisms contributes to the development of a child’s immune system.
New study highlights need for treatment options for diffuse cutaneous systemic sclerosis
A new study has suggested that with current immunosuppressive therapies, about 20% of people with early or at-risk diffuse cutaneous systemic sclerosis (dcSSc) experienced worsening of skin and lung involvement within three years.
New research shows reducing stress can reverse greying of hair
A new study has suggested that while stress can accelerate hairy greying, it is not permanent and reducing stress levels can help to restore hair colour.
New study uses virtual reality to relieve burn injury-related pain in children
New research has suggested that using smartphone-based virtual reality (VR) games while changing dressings in pediatric patients with burn injuries might have an opioid-sparing effect.
HORIZON program provides treatment recommendations for patients with moderate to severe psoriasis (Part 2)
HORIZON program provides recommendations for psoriasis patients with specific joint involvement. Dr. Wayne Gulliver, Chair and Medical Director of NewLab Clinical Research in St, John’s, speaks about the efficacy of IL-17 inhibitors and TNFs for treatment of psoriatic arthritis.
HORIZON program provides treatment recommendations for patients with moderate to severe psoriasis (Part 1)
HORIZON program provides recommendations for psoriasis patients with specific joint involvement. Dr. Ron Vender, Regional Chair of the HORIZON Program, speaks about secukinumab in use for scalp psoriasis, nail psoriasis and palmoplantar psoriasis.
Majority of fluorinated compounds in cosmetics are unlabeled, new research suggests
New research has suggested that a majority of cosmetic products in Canada and the US contain fluorinated compounds, such as per- and polyfluoroalkyl substances (PFAS), that are not listed on the label.
Dupilumab treatment for atopic dermatitis associated with increased ocular disease prevalence
New research has linked dupilumab treatment in atopic dermatitis (AD) patients with an increased prevalence of ocular disease when compared to other treatments.
